{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:11:23Z","timestamp":1791835883351,"version":"4.3.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013301","name":"National Parkinson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873686"],"award-info":[{"award-number":["81873686"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2020JJ3057"],"award-info":[{"award-number":["2020JJ3057"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["YX202109"],"award-info":[{"award-number":["YX202109"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001262","name":"National Parkinson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.arr.2023.101957","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T02:09:29Z","timestamp":1684894169000},"page":"101957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The role of the PLA2G6 gene in neurodegenerative diseases"],"prefix":"10.1016","volume":"89","author":[{"given":"Xinyue","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3240-4352","authenticated-orcid":false,"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2023.101957_bib1","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1016\/S0021-9258(17)37098-9","article-title":"Ca2+-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization","volume":"269","author":"Ackermann","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.101957_bib2","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/mds.25160","article-title":"Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism","volume":"27","author":"Agarwal","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib3","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000557","article-title":"Genome-wide association study meta-analysis for Parkinson disease motor subtypes","volume":"7","author":"Alfradique-Dunham","year":"2021","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00234-016-1726-6","article-title":"Validation of the finding of hypertrophy of the clava in infantile neuroaxonal dystrophy\/PLA2G6 by biometric analysis","volume":"58","author":"Al-Maawali","year":"2016","journal-title":"Neuroradiology"},{"key":"10.1016\/j.arr.2023.101957_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13023-020-01479-5","article-title":"The infantile neuroaxonal dystrophy rating scale (INAD-RS)","volume":"15","author":"Atwal","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.arr.2023.101957_bib6","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1074\/jbc.272.13.8576","article-title":"Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells","volume":"272","author":"Balboa","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.101957_bib7","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.cellsig.2005.03.002","article-title":"Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells","volume":"17","author":"Balsinde","year":"2005","journal-title":"Cell. Signal."},{"key":"10.1016\/j.arr.2023.101957_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13104-016-2102-7","article-title":"Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families","volume":"9","author":"Bohlega","year":"2016","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.arr.2023.101957_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2018.02.010","article-title":"Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration","volume":"49","author":"Chen","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/brainsci12050517","article-title":"Clinical characterization and founder effect analysis in Chinese patients with phospholipase A2-associated neurodegeneration","volume":"12","author":"Cheng","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2023.101957_bib11","doi-asserted-by":"crossref","first-page":"79046","DOI":"10.18632\/oncotarget.20893","article-title":"PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2023.101957_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12883-020-01684-6","article-title":"Genotype-phenotype correlations of adult-onset PLA2G6-associated neurodegeneration: case series and literature review","volume":"20","author":"Chu","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ymgme.2010.02.009","article-title":"Multiplex ligation-dependent probe amplification (MLPA) analysis is an effective tool for the detection of novel intragenic PLA2G6 mutations: implications for molecular diagnosis","volume":"100","author":"Crompton","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.arr.2023.101957_bib14","doi-asserted-by":"crossref","first-page":"147.e1","DOI":"10.1016\/j.neurobiolaging.2020.07.004","article-title":"PLA2G6 variants associated with the number of affected alleles in Parkinson\u2019s disease in Japan","volume":"97","author":"Daida","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2023.101957_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.10.013","article-title":"PLA2G6-associated neurodegeneration: new insights into brain abnormalities and disease progression","volume":"61","author":"Darling","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/jmedgenet-2015-103338","article-title":"Disruption of Golgi morphology and altered protein glycosylation in PLA2G6-associated neurodegeneration","volume":"53","author":"Davids","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3233\/JPD-181421","article-title":"The role of TMEM230 gene in Parkinson's disease","volume":"8","author":"Deng","year":"2018","journal-title":"J. Parkinson's Dis."},{"key":"10.1016\/j.arr.2023.101957_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2023.101957_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41392-021-00736-8","article-title":"Human genetic basis of coronavirus disease 2019","volume":"6","author":"Deng","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2023.101957_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic-a call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib21","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2023.101957_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.690899","article-title":"Insights into clinical, genetic, and pathological aspects of hereditary spastic paraplegias: a comprehensive overview","volume":"8","author":"Elsayed","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.arr.2023.101957_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012897","article-title":"Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism","volume":"5","author":"Engel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2023.101957_bib24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00702-021-02355-7","article-title":"Insights into Lewy body disease from rare neurometabolic disorders","volume":"128","author":"Erskine","year":"2021","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2023.101957_bib25","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.3390\/ijms22147630","article-title":"Parkinson's disease-related genes and lipid alteration","volume":"22","author":"Fais","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.101957_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fneur.2018.00536","article-title":"Heterozygous PLA2G6 mutation leads to iron accumulation within basal ganglia and Parkinson\u2019s disease","volume":"9","author":"Ferese","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib27","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.3390\/ijms22094643","article-title":"Genes implicated in familial Parkinson's disease provide a dual picture of nigral dopaminergic neurodegeneration with mitochondria taking center stage","volume":"22","author":"Franco","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2023.101957_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08712","article-title":"The GARP complex is required for cellular sphingolipid homeostasis","volume":"4","author":"Fr\u00f6hlich","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.arr.2023.101957_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seizure.2016.07.013","article-title":"Identification of a novel mutation in PLA2G6 gene in a Chinese pedigree with familial cortical myoclonic tremor with epilepsy","volume":"41","author":"Gao","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.arr.2023.101957_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5334\/tohm.289","article-title":"PLA2G6 mutations related to distinct phenotypes: a new case with early-onset parkinsonism","volume":"6","author":"Giri","year":"2016","journal-title":"Tremor Other Hyperkinet. Mov."},{"key":"10.1016\/j.arr.2023.101957_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/01.wnl.0000327094.67726.28","article-title":"Neurodegeneration associated with genetic defects in phospholipase A2","volume":"71","author":"Gregory","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.101957_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.parkreldis.2012.07.016","article-title":"Four novel rare mutations of PLA2G6 in Chinese population with Parkinson\u2019s disease","volume":"19","author":"Gui","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib33","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1007\/s12035-016-9991-2","article-title":"Identification of novel compound mutations in PLA2G6-associated neurodegeneration patient with characteristic MRI imaging","volume":"54","author":"Guo","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.101957_bib34","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3389\/fneur.2018.01100","article-title":"PLA2G6-associated neurodegeneration (PLAN): review of clinical phenotypes and genotypes","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2022.06.016","article-title":"PLA2G6-associated neurodegeneration in four different populations-case series and literature review","volume":"101","author":"Hanna Al-Shaikh","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/B978-0-444-63233-3.00019-1","article-title":"Neurodegeneration with brain iron accumulation","volume":"147","author":"Hayflick","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib37","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/antiox9101020","article-title":"Mitochondrial dysfunction, oxidative stress and neuroinflammation in neurodegeneration with brain iron accumulation (NBIA)","volume":"9","author":"Hinarejos","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2023.101957_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.629414","article-title":"Emerging disease-modifying therapies in neurodegeneration with brain iron accumulation (NBIA) disorders","volume":"12","author":"Iankova","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2023.101957_bib40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s13760-018-1003-z","article-title":"PLA2G6-related parkinsonism presenting as adolescent behavior","volume":"119","author":"Kamel","year":"2019","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.arr.2023.101957_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155605","article-title":"Genetic analysis of PLA2G6 in 22 Indian families with infantile neuroaxonal dystrophy, atypical late-onset neuroaxonal dystrophy and dystonia parkinsonism complex","volume":"11","author":"Kapoor","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2023.101957_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.562241","article-title":"The role of lipids in the initiation of \u03b1-synuclein misfolding","volume":"8","author":"Kiechle","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.arr.2023.101957_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.parkreldis.2015.01.010","article-title":"Neuroimaging studies and whole exome sequencing of PLA2G6-associated neurodegeneration in a family with intrafamilial phenotypic heterogeneity","volume":"21","author":"Kim","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib44","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/brain\/awv132","article-title":"Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction","volume":"138","author":"Kinghorn","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.arr.2023.101957_bib45","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/mds.26814","article-title":"PLA2G6 mutations and parkinsonism: long-term follow-up of clinical features and neuropathology","volume":"31","author":"Klein","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s10038-018-0519-7","article-title":"PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia","volume":"64","author":"Koh","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jmedgenet-2013-101634","article-title":"Recessive truncating NALCN mutation in infantile neuroaxonal dystrophy with facial dysmorphism","volume":"50","author":"K\u00f6ro\u011flu","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib48","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/01.wnl.0000310986.48286.8e","article-title":"Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)","volume":"70","author":"Kurian","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.101957_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mds.28982","article-title":"Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society Task Force - an update","volume":"37","author":"Lange","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1074\/jbc.273.1.207","article-title":"Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity","volume":"273","author":"Larsson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2023.101957_bib51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1432-1327.1999.00418.x","article-title":"The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene","volume":"262","author":"Larsson Forsell","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.arr.2023.101957_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fphar.2014.00099","article-title":"Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms","volume":"5","author":"Levi","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2023.101957_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.05.019","article-title":"Phospholipase PLA2G6, a parkinsonism-associated gene, affects Vps26 and Vps35, retromer function, and ceramide levels, similar to \u03b1-synuclein gain","volume":"28","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.arr.2023.101957_bib54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.b.32012","article-title":"PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson\u2019s disease","volume":"159B","author":"Lu","year":"2012","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.28807","article-title":"Dissecting the phenotype and genotype of PLA2G6-related parkinsonism","volume":"37","author":"Magrinelli","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.parkreldis.2015.01.001","article-title":"A novel homozygous PLA2G6 mutation causes dystonia-parkinsonism","volume":"21","author":"Malaguti","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41467-018-03193-0","article-title":"The structure of iPLA2\u03b2 reveals dimeric active sites and suggests mechanisms of regulation and localization","volume":"9","author":"Malley","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.101957_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13023-016-0436-9","article-title":"Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population","volume":"11","author":"Megahed","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.arr.2023.101957_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147066","article-title":"Loss of tyrosine hydroxylase, motor deficits and elevated iron in a mouse model of phospholipase A2G6-associated neurodegeneration (PLAN)","volume":"1748","author":"Minkley","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2023.101957_bib60","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib61","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1073\/pnas.1902958116","article-title":"Parkinson's disease-associated iPLA2-VIA\/PLA2G6 regulates neuronal functions and \u03b1-synuclein stability through membrane remodeling","volume":"116","author":"Mori","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2023.101957_bib62","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/cge.13008","article-title":"PLA2G6 mutations associated with a continuous clinical spectrum from neuroaxonal dystrophy to hereditary spastic paraplegia","volume":"92","author":"Ozes","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21415","article-title":"Characterization of PLA2G6 as a locus for dystonia-parkinsonism","volume":"65","author":"Paisan-Ruiz","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib64","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations","volume":"25","author":"Paisan-Ruiz","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2023.101957_bib65","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neurobiolaging.2010.05.009","article-title":"Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations","volume":"33","author":"Pais\u00e1n-Ruiz","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2023.101957_bib66","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.arr.2023.101957_bib67","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.arr.2023.101957_bib68","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3390\/biom10060912","article-title":"The future of targeted gene-based treatment strategies and biomarkers in Parkinson's disease","volume":"10","author":"Polissidis","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2023.101957_bib69","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1194\/jlr.R058701","article-title":"Calcium-independent phospholipases A2 and their roles in biological processes and diseases","volume":"56","author":"Ramanadham","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.arr.2023.101957_bib70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.arr.2023.101957_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2051-5960-1-12","article-title":"Extensive aggregation of alpha-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site","volume":"1","author":"Riku","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2023.101957_bib72","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/ene.12552","article-title":"Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort","volume":"22","author":"Romani","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib73","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.3390\/jcm11154524","article-title":"Long-term neuroradiological and clinical evaluation of NBIA patients treated with a deferiprone based iron-chelation therapy","volume":"11","author":"Romano","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2023.101957_bib74","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1007\/s12035-017-0846-2","article-title":"Pla2g6 deficiency in zebrafish leads to dopaminergic cell death, axonal degeneration, increased \u03b2-synuclein expression, and defects in brain functions and pathways","volume":"55","author":"S\u00e1nchez","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2023.101957_bib75","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/WNL.0b013e318221acd3","article-title":"PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort","volume":"77","author":"Shi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2023.101957_bib76","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1523\/JNEUROSCI.4354-07.2008","article-title":"Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease","volume":"28","author":"Shinzawa","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2023.101957_bib77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-1331.2008.02356.x","article-title":"R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family","volume":"16","author":"Sina","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neulet.2012.02.078","article-title":"Analysis of PLA2G6 gene mutation in sporadic early-onset parkinsonism patients from Chinese population","volume":"514","author":"Tian","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2023.101957_bib79","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-0004.2010.01417.x","article-title":"Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy","volume":"78","author":"Tonelli","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.arr.2023.101957_bib80","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1139\/y04-064","article-title":"The expression and function of a group VIA calcium-independent phospholipase A2 (iPLA2\u03b2) in \u03b2-cells","volume":"82","author":"Turk","year":"2004","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.arr.2023.101957_bib81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-016-1658-7","article-title":"Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism.","volume":"124","author":"Yamashita","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2023.101957_bib82","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/dme.12587","article-title":"Genetic variants of PLA2G6 are associated with Type 2 diabetes mellitus and triglyceride levels in a Chinese population","volume":"32","author":"Yan","year":"2015","journal-title":"Diabet. Med."},{"key":"10.1016\/j.arr.2023.101957_bib83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1468-1331.2012.03856.x","article-title":"Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration","volume":"20","author":"Zhang","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2023.101957_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026991","article-title":"Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2023.101957_bib85","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1038\/ncomms10332","article-title":"Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson\u2019s disease","volume":"7","author":"Zhou","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.101957_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.904027","article-title":"Identification of a novel nonsense mutation in PLA2G6 and prenatal diagnosis in a Chinese family with infantile neuroaxonal dystrophy","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Neurol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723001162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723001162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:14:31Z","timestamp":1761592471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163723001162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":86,"alternative-id":["S1568163723001162"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2023.101957","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the PLA2G6 gene in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2023.101957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101957"}}